DK1309593T3 - Substituerede pyrazoler - Google Patents

Substituerede pyrazoler

Info

Publication number: DK1309593T3
Authority: DK; Denmark
Prior art keywords: substituted pyrazoles; methods; pyrazoles; substituted; cathepsin
Prior art date: 2000-08-14

Application number

DK01965898T

Other languages

Danish (da)

English (en)

Inventor

Christopher R Butler

Darin J Gustin

Hui Cai

James P Edwards

Cheryl A Grice

Haripada Khatuya

Steven P Meduna

Barbara A Pio

Kevin L Tays

Jianmei Wei

Clark A Sehon

Original Assignee

Ortho Mcneil Pharm Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-14

Filing date

2001-08-10

Publication date

2006-07-17

2001-08-10 Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc

2006-07-17 Application granted granted Critical

2006-07-17 Publication of DK1309593T3 publication Critical patent/DK1309593T3/da

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/275—Nitriles; Isonitriles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Rheumatology (AREA)
Pulmonology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Transplantation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)

DK01965898T 2000-08-14 2001-08-10 Substituerede pyrazoler DK1309593T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US22517800P	2000-08-14	2000-08-14
US09/927,324 US6953793B2 (en)	2000-08-14	2001-08-10	Substituted pyrazoles

Publications (1)

Publication Number	Publication Date
DK1309593T3 true DK1309593T3 (da)	2006-07-17

Family

ID=26919364

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK01965898T DK1309593T3 (da)	2000-08-14	2001-08-10	Substituerede pyrazoler

Country Status (19)

Country	Link
US (2)	US6953793B2 (pl)
EP (1)	EP1309593B1 (pl)
JP (1)	JP5049447B2 (pl)
KR (1)	KR100837193B1 (pl)
AT (1)	ATE320427T1 (pl)
AU (2)	AU2001286454B2 (pl)
BR (1)	BRPI0113286B8 (pl)
CA (1)	CA2419552C (pl)
CZ (1)	CZ307185B6 (pl)
DE (1)	DE60118004T2 (pl)
DK (1)	DK1309593T3 (pl)
ES (1)	ES2261463T3 (pl)
HU (1)	HU230538B1 (pl)
MX (1)	MXPA03001422A (pl)
NZ (1)	NZ524191A (pl)
PL (1)	PL213103B1 (pl)
PT (1)	PT1309593E (pl)
RU (1)	RU2317988C2 (pl)
WO (1)	WO2002014315A2 (pl)

Families Citing this family (62)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6566372B1 (en)	1999-08-27	2003-05-20	Ligand Pharmaceuticals Incorporated	Bicyclic androgen and progesterone receptor modulator compounds and methods
US20050101587A9 (en) *	2000-08-14	2005-05-12	Butler Christopher R.	Method for treating allergies using substituted pyrazoles
HK1052509B (en) *	2000-08-14	2007-09-07	Ortho-Mcneil Pharmaceutical, Inc.	Substituted pyrazole
EP1309593B1 (en) *	2000-08-14	2006-03-15	Ortho-McNeil Pharmaceutical, Inc.	Substituted pyrazoles
JP2004523506A (ja) *	2000-12-22	2004-08-05	アクシス・ファーマシューティカルズ・インコーポレイテッド	カテプシン阻害剤としての新規な化合物と組成物
NZ551453A (en) *	2001-04-18	2008-02-29	Euro Celtique Sa	Nociceptin analogs for the treatment of pain
KR100855204B1 (ko) *	2001-04-18	2008-09-01	유로-셀티크 소시에떼 아노뉨	노시셉틴 유사체
US20040147503A1 (en) *	2002-06-04	2004-07-29	Sheila Zipfeil	Novel compounds and compositions as cathepsin inhibitors
KR20080103117A (ko)	2002-09-24	2008-11-26	노파르티스 아게	탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트 수용체 아고니스트
US7109243B2 (en)	2003-03-24	2006-09-19	Irm Llc	Inhibitors of cathepsin S
US7384970B2 (en)	2003-03-24	2008-06-10	Irm Llc	Inhibitors of cathepsin S
US7173051B2 (en)	2003-06-13	2007-02-06	Irm, Llc	Inhibitors of cathepsin S
US7256207B2 (en)	2003-08-20	2007-08-14	Irm Llc	Inhibitors of cathepsin S
FR2885904B1 (fr) *	2005-05-19	2007-07-06	Aventis Pharma Sa	Nouveaux derives du fluorene, compositions les contenant et utilisation
BRPI0612112A8 (pt) *	2005-06-22	2017-12-26	Chemocentryx Inc	composto, composição farmacêutica, e, método de tratar doenças ou condições mediadas por ccr1.
TW200813018A (en)	2006-06-09	2008-03-16	Astrazeneca Ab	Novel compounds
CL2007003590A1 (es) *	2006-12-12	2008-02-29	Wyeth Corp	Compuestos derivados de aril sulfamida; procedimiento de preparacion; composicion farmaceutica que comprende a dichos compuestos; y su uso en prevencion y tratamiento de sintomas vasomotrices, disfuncion sexual, transtornos gastrointestinales, transt
US20090118274A1 (en) *	2007-02-15	2009-05-07	Darin Allen	Monocyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20090099157A1 (en) *	2007-02-15	2009-04-16	Ameriks Michael K	Tetrahydro-pyrazolo-pyridine thioether modulators of cathepsin s
US20080207683A1 (en) *	2007-02-15	2008-08-28	Darin Allen	Biaryl-substituted tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080200454A1 (en) *	2007-02-15	2008-08-21	Ameriks Michael K	Carbon-linked tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US20080269241A1 (en) *	2007-02-15	2008-10-30	Darin Allen	Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
US8119661B2 (en)	2007-09-11	2012-02-21	Astrazeneca Ab	Piperidine derivatives and their use as muscarinic receptor modulators
KR20110020928A (ko)	2008-06-20	2011-03-03	노파르티스 아게	다발성 경화증을 치료하기 위한 소아용 조성물
US9643922B2 (en)	2008-08-18	2017-05-09	Yale University	MIF modulators
US9540322B2 (en)	2008-08-18	2017-01-10	Yale University	MIF modulators
PE20110368A1 (es) *	2008-08-18	2011-06-13	Univ Yale	Moduladores de mif
TWI475020B (zh) *	2009-03-12	2015-03-01		The substituted nicotine amide as a KCNQ2 / 3 modifier
JP2013501804A (ja) *	2009-08-12	2013-01-17	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	カテプシンｓ阻害剤の調製プロセス
US8754114B2 (en)	2010-12-22	2014-06-17	Incyte Corporation	Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3
ES2704744T3 (es)	2012-06-13	2019-03-19	Incyte Holdings Corp	Compuestos tricíclicos sustituidos como inhibidores de FGFR
US9388185B2 (en)	2012-08-10	2016-07-12	Incyte Holdings Corporation	Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors
US9458137B2 (en)	2012-11-05	2016-10-04	Nantbioscience, Inc.	Substituted indol-5-ol derivatives and their therapeutical applications
EP2920183B1 (en)	2012-11-14	2017-03-08	Glaxosmithkline LLC	Thieno[3,2-c]pyridin-4(5h)-ones as bet inhibitors
US9266892B2 (en)	2012-12-19	2016-02-23	Incyte Holdings Corporation	Fused pyrazoles as FGFR inhibitors
US9550760B2 (en)	2013-03-15	2017-01-24	Nantbioscience, Inc.	Substituted indol-5-ol derivatives and their therapeutic applications
EA035095B1 (ru)	2013-04-19	2020-04-27	Инсайт Холдингс Корпорейшн	Бициклические гетероциклы в качестве ингибиторов fgfr
US10851105B2 (en)	2014-10-22	2020-12-01	Incyte Corporation	Bicyclic heterocycles as FGFR4 inhibitors
JP6654636B2 (ja) *	2014-12-02	2020-02-26	エフ．ホフマン−ラロシュアーゲーＦ．Ｈｏｆｆｍａｎｎ−ＬａＲｏｃｈｅＡｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ	新規ピペリジン誘導体
MX373169B (es)	2015-02-20	2020-04-24	Incyte Holdings Corp	Heterociclos bicíclicos como inhibidores de receptores del factor de crecimiento fibroblástico (fgfr).
WO2016134294A1 (en)	2015-02-20	2016-08-25	Incyte Corporation	Bicyclic heterocycles as fgfr4 inhibitors
MA41551A (fr)	2015-02-20	2017-12-26	Incyte Corp	Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4
EP3319968A1 (en)	2015-07-06	2018-05-16	Rodin Therapeutics, Inc.	Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase
LT3319959T (lt)	2015-07-06	2021-12-27	Alkermes, Inc.	Histono deacetilazės hetero-halogeno inhibitoriai
RS62959B1 (sr)	2017-01-11	2022-03-31	Alkermes Inc	Biciklični inhibitori histon-deacetilaze
AR111960A1 (es)	2017-05-26	2019-09-04	Incyte Corp	Formas cristalinas de un inhibidor de fgfr y procesos para su preparación
US11225475B2 (en)	2017-08-07	2022-01-18	Alkermes, Inc.	Substituted pyridines as inhibitors of histone deacetylase
JP7110360B2 (ja)	2017-10-09	2022-08-01	テルモビーシーティーバイオテクノロジーズ，エルエルシー	凍結乾燥方法
CR20200590A (es)	2018-05-04	2021-04-26	Incyte Corp	Formas sólidas de un inhibidor de fgfr y procesos para prepararlas
MA52493A (fr)	2018-05-04	2021-03-10	Incyte Corp	Sels d'un inhibiteur de fgfr
WO2020185532A1 (en)	2019-03-08	2020-09-17	Incyte Corporation	Methods of treating cancer with an fgfr inhibitor
CN113614477B (zh)	2019-03-14	2023-04-28	泰尔茂比司特生物技术有限公司	冷冻干燥装载托盘组件及系统
WO2021007269A1 (en)	2019-07-09	2021-01-14	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
WO2021067374A1 (en)	2019-10-01	2021-04-08	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
TWI891666B (zh)	2019-10-14	2025-08-01	美商英塞特公司	作為ｆｇｆｒ抑制劑之雙環雜環
WO2021076728A1 (en)	2019-10-16	2021-04-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
BR112022010664A2 (pt)	2019-12-04	2022-08-16	Incyte Corp	Derivados de um inibidor de fgfr
EP4069696A1 (en)	2019-12-04	2022-10-12	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
WO2021146424A1 (en)	2020-01-15	2021-07-22	Incyte Corporation	Bicyclic heterocycles as fgfr inhibitors
TW202304459A (zh)	2021-04-12	2023-02-01	美商英塞特公司	包含ｆｇｆｒ抑制劑及ｎｅｃｔｉｎ－４靶向劑之組合療法
EP4352059A1 (en)	2021-06-09	2024-04-17	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors
WO2022261159A1 (en)	2021-06-09	2022-12-15	Incyte Corporation	Tricyclic heterocycles as fgfr inhibitors

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US856514A (en) *	1907-03-15	1907-06-11	William T Adams	Cheese-cutter.
US3743409A (en)	1971-06-11	1973-07-03	Xerox Corp	Cutter assembly
JPS5090172A (pl)	1973-12-13	1975-07-19
US3994890A (en)	1974-01-31	1976-11-30	Chugai Seiyaku Kabushiki Kaisha	1-Aminoalkyl, 3-phenyl indazoles
JPS5640714B2 (pl) *	1974-03-04	1981-09-22
DK27383A (da)	1982-02-17	1983-08-18	Lepetit Spa	Fremgangsmaade til fremstilling af pyrazol(4,3-c)pyridiner
JPH0615542B2 (ja)	1986-07-22	1994-03-02	吉富製薬株式会社	ピラゾロピリジン化合物
FR2642759B1 (fr)	1989-02-09	1991-05-17	Laboratorios Esteve Sa	Derives de pyrimidyl-piperazinyl-alkyl azoles avec activite anxiolytique et/ou tranquillisante
FR2673628B1 (fr)	1991-03-07	1993-07-09	Esteve Labor Dr	Procede de preparation de derives d'aryl (ou heteroaryl)-piperazinyl-butyl-azoles.
US5264576A (en)	1992-10-22	1993-11-23	Hoechst-Roussel Pharmaceuticals Incorporated	Pyrazolo[4,3-c]pyridines which are intermediates
FR2705962B1 (fr) *	1993-06-03	1995-07-13	Rhone Poulenc Agrochimie	Arylpyrazoles fongicides.
RU2131876C1 (ru) *	1993-07-06	1999-06-20	Пфайзер Инк.	Бициклические тетрагидропиразолпиридины или их фармацевтически приемлемые соли, фармацевтическая композиция, способ ингибирования фосфодиэстеразы, способ лечения
FR2712808B1 (fr)	1993-11-25	1996-02-16	Esteve Labor Dr	Utilisation des dérivés de 1-{4-[4-aryl(ou hétéroaryl)-1-pipérazinyl]-butyl}-1-H-azole pour la préparation de médicaments destinés au traitement des troubles de la sécrétion gastrique .
IL112759A0 (en)	1994-02-25	1995-05-26	Khepri Pharmaceuticals Inc	Novel cysteine protease inhibitors
AU713492B2 (en)	1995-03-24	1999-12-02	Axys Pharmaceuticals, Inc.	Reversible protease inhibitors
US5776718A (en)	1995-03-24	1998-07-07	Arris Pharmaceutical Corporation	Reversible protease inhibitors
TW438591B (en)	1995-06-07	2001-06-07	Arris Pharm Corp	Reversible cysteine protease inhibitors
FR2742052B1 (fr)	1995-12-12	1998-04-10	Esteve Labor Dr	Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
CA2251714A1 (en)	1996-04-22	1997-10-30	Massachusetts Institute Of Technology	Suppression of immune response via inhibition of cathepsin s
AU7553198A (en)	1997-06-12	1998-12-30	Sumitomo Pharmaceuticals Company, Limited	Pyrazole derivatives
TR200001189T2 (tr)	1997-11-05	2000-09-21	Novartis Ag.	Dipeptid nitriller.
GB9806287D0 (en)	1998-03-24	1998-05-20	Synphar Lab Inc	Monobactam enzyme inhibitors
WO1999058153A1 (en)	1998-05-08	1999-11-18	Brigham & Women's Hospital	Methods of diagnosing and modulating autoimmunity
AU2560000A (en)	1999-02-20	2000-09-04	Astrazeneca Ab	Di- and tripeptide nitrile derivatives as inhibitors of cathepsin l and cathepsin
WO2000051998A1 (en)	1999-03-02	2000-09-08	Boehringer Ingelheim Pharmaceuticals, Inc.	Compounds useful as reversible inhibitors of cathepsin s
TW200404789A (en)	1999-03-15	2004-04-01	Axys Pharm Inc	Novel compounds and compositions as protease inhibitors
JP2003506364A (ja)	1999-07-30	2003-02-18	ベーリンガーインゲルハイムファーマシューティカルズインコーポレイテッド	システインプロテアーゼインヒビターとして有益な新規スクシネート誘導体化合物
CA2384974A1 (en)	1999-09-16	2001-03-22	Axys Pharmaceuticals, Inc.	Compounds and pharmaceutical compositions as cathepsin s inhibitors
EP1234821A4 (en)	1999-12-03	2002-10-28	Ono Pharmaceutical Co	1,3,4-OXADIAZOLINE DERIVATIVES AND MEDICINES THAT CONTAIN THEIR ACTIVE SUBSTANCE
EP1309593B1 (en) *	2000-08-14	2006-03-15	Ortho-McNeil Pharmaceutical, Inc.	Substituted pyrazoles

2001
- 2001-08-10 EP EP01965898A patent/EP1309593B1/en not_active Expired - Lifetime
- 2001-08-10 DE DE60118004T patent/DE60118004T2/de not_active Expired - Lifetime
- 2001-08-10 ES ES01965898T patent/ES2261463T3/es not_active Expired - Lifetime
- 2001-08-10 KR KR1020037002163A patent/KR100837193B1/ko not_active Expired - Lifetime
- 2001-08-10 NZ NZ524191A patent/NZ524191A/en not_active IP Right Cessation
- 2001-08-10 RU RU2003107016/04A patent/RU2317988C2/ru not_active Application Discontinuation
- 2001-08-10 WO PCT/US2001/025290 patent/WO2002014315A2/en not_active Ceased
- 2001-08-10 BR BRPI0113286A patent/BRPI0113286B8/pt not_active IP Right Cessation
- 2001-08-10 AU AU2001286454A patent/AU2001286454B2/en not_active Expired
- 2001-08-10 DK DK01965898T patent/DK1309593T3/da active
- 2001-08-10 MX MXPA03001422A patent/MXPA03001422A/es active IP Right Grant
- 2001-08-10 US US09/927,324 patent/US6953793B2/en not_active Expired - Lifetime
- 2001-08-10 CA CA2419552A patent/CA2419552C/en not_active Expired - Lifetime
- 2001-08-10 CZ CZ2003-429A patent/CZ307185B6/cs not_active IP Right Cessation
- 2001-08-10 HU HU0303108A patent/HU230538B1/hu not_active IP Right Cessation
- 2001-08-10 AT AT01965898T patent/ATE320427T1/de active
- 2001-08-10 PT PT01965898T patent/PT1309593E/pt unknown
- 2001-08-10 PL PL360696A patent/PL213103B1/pl unknown
- 2001-08-10 AU AU8645401A patent/AU8645401A/xx active Pending
- 2001-08-10 JP JP2002519455A patent/JP5049447B2/ja not_active Expired - Lifetime
2005
- 2005-06-30 US US11/174,077 patent/US20050245576A1/en not_active Abandoned

Also Published As

Publication number	Publication date
HK1055422A1 (en)	2004-01-09
ES2261463T3 (es)	2006-11-16
PT1309593E (pt)	2006-08-31
WO2002014315A2 (en)	2002-02-21
RU2003107016A (ru)	2004-11-27
AU2001286454B2 (en)	2006-09-14
CZ2003429A3 (cs)	2003-12-17
BR0113286B1 (pt)	2013-04-16
HUP0303108A2 (hu)	2004-01-28
EP1309593A2 (en)	2003-05-14
CZ307185B6 (cs)	2018-03-07
DE60118004T2 (de)	2006-11-16
HUP0303108A3 (en)	2012-10-29
BRPI0113286B8 (pt)	2021-05-25
ATE320427T1 (de)	2006-04-15
US20050245576A1 (en)	2005-11-03
JP2004511440A (ja)	2004-04-15
JP5049447B2 (ja)	2012-10-17
AU8645401A (en)	2002-02-25
CA2419552C (en)	2010-10-12
BR0113286A (pt)	2003-09-09
HU230538B1 (hu)	2016-11-28
DE60118004D1 (de)	2006-05-11
CA2419552A1 (en)	2002-02-21
KR20030060876A (ko)	2003-07-16
EP1309593B1 (en)	2006-03-15
US20030078419A1 (en)	2003-04-24
US6953793B2 (en)	2005-10-11
WO2002014315A3 (en)	2002-06-13
RU2317988C2 (ru)	2008-02-27
PL213103B1 (pl)	2013-01-31
PL360696A1 (pl)	2004-09-20
KR100837193B1 (ko)	2008-06-13
MXPA03001422A (es)	2004-01-26
NZ524191A (en)	2004-11-26

Publication	Publication Date	Title
DK1309593T3 (da)	2006-07-17	Substituerede pyrazoler
DK1309592T3 (da)	2006-08-21	Substituerede pyrazoler
WO2002014314A3 (en)	2002-06-06	Substituted pyrazoles
NO20030845D0 (no)	2003-02-24	Utvalgte fusjonerte pyrrolokarbazoler
BG66084B1 (bg)	2011-03-31	Циклопентаноиндоли, състави,съдържащи такива съединения и използването им
BG66080B1 (bg)	2011-03-31	Заместени тиоацетамиди
NO991732L (no)	1999-06-04	Nye heterocyklylmetylsubstituerte pyrazolderivater
SG149045A1 (en)	2009-01-29	Novel fused pyrrolocarbazoles
SG149042A1 (en)	2009-01-29	Novel fused pyrrolocarbazoles
TR200402030T4 (tr)	2004-09-21	İkame edilen I-aminobutan-3-ol-türevleri
DK1438034T3 (da)	2008-12-01	Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
ATE247130T1 (de)	2003-08-15	Inhibitoren für den urokinaserezeptor
UA87829C2 (en)	2009-08-25	Fused pyrrolocarbazoles
CY1111290T1 (el)	2015-08-05	Παραγωγα 9-αλκυλαμινo-1-νιτρoακριδινης
ATE423780T1 (de)	2009-03-15	Makrozyclen zur behandlung von krebserkrankungen
SE0001631D0 (sv)	2000-05-04	New use
BR0111221A (pt)	2003-03-18	Condensados glioxal-fenólicos com fluorescência intensificada